340B Report

Drug Industry Files New Lawsuits to Block 340B Contract Pharmacy Access Laws in Tennessee, Utah

May 28, 2025 William Newton, Associate Editor/Senior Writer Views

AstraZeneca sued to block Utah's 340B contract pharmacy access law one day after PhRMA challenged Tennessee's similar statute.

AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sponsors of Oklahoma’s 340B Contract Pharmacy Access Bill Call for Veto Override, Slam ‘Big Pharma’ and Dark Money

May 22, 2025 William Newton, Associate Editor/Senior Writer Views

Oklahoma Sen. Brent Howard (R), who sponsored a 340B contract pharmacy access bill that the governor recently vetoed, is urging his colleagues to override that veto.

Two Oklahoma Republican lawmakers are urging their colleagues to override Gov. Kevin Stitt’s (R) veto of a 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amid Federal Court Setbacks, Drugmakers Turn to State Courts to Try to Block 340B Contract Pharmacy Access Laws

May 22, 2025 William Newton, Associate Editor/Senior Writer Views

The Arkansas Circuit Court of Pulaski County is one of two state courts with drug industry litigation challenging 340B contract pharmacy access laws.

Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Webinar —Behind the Headlines: A 340B Insider Briefing with Ted Slafsky

May 22, 2025 Sponsored Content Views

Join Cervey for this Important Briefing May 27^th
from 10-11AM CST

340B Provider-Drugmaker Lobbying Group Adds Hospital, Drugmaker: Key Thune Staffer Departs for Private Sector

May 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

The 340B Working Table has added Boston Medical Center Health System and Takeda Pharmaceuticals America to its list of members.

A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Tightens Contract Pharmacy Restrictions to Require Hospital Claims Data, Targets 340B Drug Redistribution; 340B Lawyer Pushes Back

May 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Genentech updated its contract pharmacy restrictions to impose new claims data submissions and prevent covered entities from shipping 340B drugs to other locations through “alternate distribution models” or other channels.

A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Key Briefs in 8th Circuit, Utah, South Dakota; Motion Filed in 5th Circuit

May 22, 2025 Bella Czajkowski, National Correspondent Views

Key briefs and motions were filed recently in the 8th Circuit and 5th Circuit Appeals Courts, as well as federal district courts in Utah and South Dakota.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

RFK Jr. Tells Senate Panel 340B Program ‘Controversial’ But Important to Rural Hospitals; HHS Releases MFN Targets for Drugmakers

May 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

HHS Secretary Robert F. Kennedy Jr. told a Senate subcommittee Tuesday that the 340B program plays an important role for rural hospitals despite being “very controversial."

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

May 20, 2025 William Newton, Associate Editor/Senior Writer Views

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.

A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Blog Posts

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live